Study guide

5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit

Oregon Multistate Pharmacy Jurisprudence Examination MPJE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Oregon Legal Framework

1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy

2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities

2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection

3 Chapter 3: Pharmacy Technicians, Interns & Preceptors

3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision

4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners

4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)

5 Chapter 5: Prescriber Authority & Prescription Requirements

5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority

6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine

7 Chapter 7: Counseling, Language Access & Confidentiality

7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy

8 Chapter 8: The Dispensing Process

8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse

9 Chapter 9: Nonprescription & Restricted Products

9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others

10 Chapter 10: Product Selection: Generic & Biologic Substitution

10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)

11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting

11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles

12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings

12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies

13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice

13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks

5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit

Key Takeaways Explain This Topic AI

In Oregon, a paper or faxed controlled substance prescription needs the prescriber's original manual signature, never a stamp or an agent's signature, and an electronic one needs a DEA-compliant EPCS digital signature.

A Schedule II prescription can never be refilled. A practitioner may issue multiple Schedule II prescriptions on one day for up to a 90-day supply, each with the actual issue date and an earliest-fill date.

For an emergency oral Schedule II order, the prescriber must deliver a written prescription within 7 days, and the pharmacist must notify DEA if it does not arrive. Oregon has no shorter deadline.

Oregon limits Schedule III, IV and V prescription drugs to 6 months from issue and 5 refills (ORS 475.185), which is stricter than federal law for Schedule V.

Pseudoephedrine and ephedrine are Schedule V in Oregon, and gabapentin is unscheduled but reported to Oregon's PDMP.

Last updated: October 2026

Why this matters

Controlled substance prescriptions are a large part of the MPJE. Oregon follows the federal CSA framework through ORS 475.185 and OAR 855-080-0085, which adopts 21 CFR by reference, and adds stricter limits. The most important Oregon difference is that Schedule V prescription drugs are capped at 6 months and 5 refills , like Schedules III and IV.

Elements of a controlled substance prescription

Federal rule 21 CFR 1306.05 requires the prescription to be dated and signed on the day it is issued, and to contain:

The patient's full name and address .

The drug's name, strength, dosage form and quantity .

Directions for use .

The practitioner's name, address and DEA registration number .

Oregon adds the patient's date of birth and the prescriber's phone number (OAR 855-041-1105). Signature rules (OAR 855-041-1105(2)(g)(B)):

  • Transmission Valid signature
  • Paper Original manual signature of the prescriber. Not an agent, and not a stamp
  • Fax Original manual signature of the prescriber on the faxed document

Electronic Prescriber's digital signature under DEA's electronic prescriptions for controlled substances (EPCS) rule (21 CFR 1311): certified software, identity proofing and two-factor authentication

Agents may prepare a controlled substance prescription for the prescriber's signature, but only the prescriber may sign it.

Schedule II rules

Written or electronic prescription required (ORS 475.185(1); 21 CFR 1306.11(a)). No refills .

Fax as the original is allowed only for:

A Schedule II narcotic compounded for home infusion or IV pain therapy .

Any Schedule II drug for a long-term care facility (LTCF) resident.

A Schedule II narcotic for a hospice patient, certified by Medicare or licensed by the state.

Multiple prescriptions (21 CFR 1306.12(b)): a practitioner may issue several Schedule II prescriptions on the same day for up to a 90-day supply . Each must bear the actual issue date and written instructions for the earliest fill date, and the practitioner must find no undue risk of diversion.

No federal or Oregon expiration date applies to Schedule II prescriptions. A pharmacist presented with a months-old order uses corresponding responsibility, covered in section 5.5.

Emergency oral Schedule II orders (21 CFR 1306.11(d); ORS 475.185(1)(b))

In a true emergency, meaning immediate administration is needed, no appropriate alternative exists, and a written order cannot be provided first, a pharmacist may dispense on an oral order. The conditions are:

The quantity is limited to the amount adequate to treat the patient during the emergency period .

The pharmacist immediately reduces the order to writing with every required element except the signature.

The pharmacist makes a reasonable effort to verify an unknown prescriber, for example by calling back on a published number.

Within 7 days , the prescriber delivers a written or electronic prescription marked "Authorization for Emergency Dispensing" with the date of the oral order. A mailed prescription must be postmarked within the 7 days.

If it does not arrive, the pharmacist must notify the nearest DEA office . Failing to do so voids the authority under which the drug was dispensed.

Oregon has no separate shorter deadline. The federal 7-day rule applies through OAR 855-080-0085.

Schedules III, IV and V

  • Rule Federal (21 CFR 1306.21–.22) Oregon
  • Prescription form Written, oral, fax or electronic Same
  • CIII–CIV refills Up to 5 refills within 6 months of issue Same (ORS 475.185(2); OAR 855-041-1120(1))

CV refills As the prescriber authorizes Not filled or refilled more than 6 months after issue, and no more than 5 refills (ORS 475.185(3))

  • "PRN" alone Not defined Six months or five refills, whichever comes first (OAR 855-041-1125)
  • More medication after the limits New prescription New prescription only

Important

An Oregon prescription for pregabalin (Schedule V) "with 11 refills for 1 year" may be refilled at most 5 times within 6 months of issue. The Oregon statute is stricter than federal law, so it governs.

Changing a controlled substance prescription

The patient's name , the controlled substance prescribed (except a permitted generic substitution) and the prescriber's signature can never be changed. A wrong patient name, a missing signature or a different drug requires a new prescription. Other defects, such as strength, dosage form, quantity, directions or a missing DEA number, may be clarified with the prescriber, with the conversation documented. Under OAR 855-041-1115, any unauthorized alteration makes a written order invalid.

Oregon scheduling notes

Oregon's schedules generally track the federal schedules (OAR 855-080-0021 to -0026). Schedule I adds state-specific structural classes.

Pseudoephedrine and ephedrine are Schedule V in Oregon. They may be sold without a prescription only under ORS 475.230 (Chapter 9).

Gabapentin is not scheduled, but Oregon requires PDMP reporting for it (ORS 431A.855).

Federal marijuana status changed in 2026. A final order signed April 22, 2026 moved FDA-approved marijuana drug products and marijuana handled under a state medical-marijuana license to Schedule III . Adult-use marijuana remains Schedule I , and broader rescheduling was paused in late September 2026. Psilocybin remains federally Schedule I, although Oregon licenses psilocybin services under ORS chapter 475A. Pharmacies do not dispense marijuana items or psilocybin.

Exam scenario

On Friday evening a hospice physician phones in hydromorphone 2 mg #20 for a home-hospice patient in a pain crisis. The pharmacist reduces the order to writing and dispenses an amount adequate for the emergency period. The written prescription marked "Authorization for Emergency Dispensing" is due within 7 days . If it never arrives, the pharmacist must notify DEA. Separately, a prescription for hydromorphone for a hospice patient may be faxed as the original if the faxed document carries the prescriber's manual signature.